Literature DB >> 3955886

Some side effects of intravenous 7S-immunoglobulins are due to immune complexes and can be prevented by 5S-immunoglobulin given prior to 7S treatment.

G P Tilz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3955886      PMCID： PMC1577325     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  5 in total

1.  Intravenous administration of human gamma-globulin.

Authors:  S BARANDUN; P KISTLER; F JEUNET; H ISLIKER
Journal:  Vox Sang       Date:  1962       Impact factor: 2.144

2.  Intravenous immunoglobulin in antibody deficiency syndromes.

Authors:  L A Hanson; J Björkander; C Wadsworth; B Bake
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

3.  Undegraded human immunoglobulin for intravenous use.

Authors:  W Stephan
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

4.  [Clinical results with a new intravenous immunoglobulin preparation (author's transl)].

Authors:  W Hansi; G Kratzsch; H Heimpel
Journal:  Dtsch Med Wochenschr       Date:  1980-11-28       Impact factor: 0.628

5.  Safety and patient acceptability of intravenous immune globulin in 10% maltose.

Authors:  H D Ochs; R H Buckley; B Pirofsky; S H Fischer; R H Rousell; C J Anderson; R J Wedgwood
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.